# Originclear, Inc.: overview OCLN · OTC · CIK 1419793 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ocln.md) · [Financials](/companies/ocln/financials.md) · [Filings](/companies/ocln/filings.md) · [Insiders](/companies/ocln/insiders.md) Latest reported revenue: [$2.0m](/filings/0001096906-26-000879.md) for Q1 FY2026, three months to 2026-03-31, from the 10-Q filed May 29, 2026 (XBRL us-gaap:Revenues, accession 0001096906-26-000879). ## Last eight quarters | Line item | Unit | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,051](/filings/0001213900-25-077581.md) | [583](/filings/0001213900-25-112670.md) | [1,830 d](/filings/0001213900-26-042634.md) | [1,405](/filings/0001096906-26-000879.md) | [942](/filings/0001213900-25-077581.md) | [1,709](/filings/0001213900-25-112670.md) | [2,762 d](/filings/0001213900-26-042634.md) | [2,003](/filings/0001096906-26-000879.md) | | Gross margin | % | [61.2%](/filings/0001213900-25-077581.md) | [12.2%](/filings/0001213900-25-112670.md) | [49.4% d](/filings/0001213900-26-042634.md) | [35.9%](/filings/0001096906-26-000879.md) | [(69.9%)](/filings/0001213900-25-077581.md) | [28.2%](/filings/0001213900-25-112670.md) | [46.8% d](/filings/0001213900-26-042634.md) | [27.7%](/filings/0001096906-26-000879.md) | | Operating margin | % | [(86.2%)](/filings/0001213900-25-077581.md) | [(376.9%)](/filings/0001213900-25-112670.md) | [(64.1%) d](/filings/0001213900-26-042634.md) | [(66.3%)](/filings/0001096906-26-000879.md) | [(182.0%)](/filings/0001213900-25-077581.md) | [(18.7%)](/filings/0001213900-25-112670.md) | [(12.5%) d](/filings/0001213900-26-042634.md) | [(25.0%)](/filings/0001096906-26-000879.md) | | Net margin | % | [282.0%](/filings/0001213900-25-077581.md) | [(475.5%)](/filings/0001213900-25-112670.md) | [(120.3%) d](/filings/0001213900-26-042634.md) | [(46.7%)](/filings/0001096906-26-000879.md) | [(1920.0%)](/filings/0001213900-25-077581.md) | [(772.8%)](/filings/0001213900-25-112670.md) | [474.9% d](/filings/0001213900-26-042634.md) | [(114.1%)](/filings/0001096906-26-000879.md) | | Diluted EPS | $ per share | [0.00](/filings/0001213900-24-068900.md) | not reported | not reported | [0.00](/filings/0001096906-26-000879.md) | not reported | not reported | not reported | [0.00](/filings/0001096906-26-000879.md) | | Free cash flow | $k | not reported | not reported | not reported | [(229)](/filings/0001096906-26-000879.md) | not reported | not reported | not reported | [1,512](/filings/0001096906-26-000879.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [4.1](/filings/0001213900-23-030192.md) | [10.4](/filings/0001213900-23-030192.md) | [6.7](/filings/0001213900-25-026104.md) | [4.4](/filings/0001213900-26-042634.md) | [6.8](/filings/0001213900-26-042634.md) | | Gross margin | % | [13.7%](/filings/0001213900-23-030192.md) | [14.4%](/filings/0001213900-23-030192.md) | [9.3%](/filings/0001213900-25-026104.md) | [34.1%](/filings/0001213900-26-042634.md) | [23.8%](/filings/0001213900-26-042634.md) | | Operating margin | % | [(145.9%)](/filings/0001213900-23-030192.md) | [(63.4%)](/filings/0001213900-23-030192.md) | [(98.7%)](/filings/0001213900-25-026104.md) | [(140.6%)](/filings/0001213900-26-042634.md) | [(48.7%)](/filings/0001213900-26-042634.md) | | Net margin | % | [(51.1%)](/filings/0001213900-23-030192.md) | [(104.0%)](/filings/0001213900-23-030192.md) | [(173.3%)](/filings/0001213900-25-026104.md) | [(412.4%)](/filings/0001213900-26-042634.md) | [(268.7%)](/filings/0001213900-26-042634.md) | | Diluted EPS | $ per share | [(0.02)](/filings/0001213900-23-030192.md) | [(0.02)](/filings/0001213900-23-030192.md) | [(0.01)](/filings/0001213900-25-026104.md) | [(0.01)](/filings/0001213900-25-026104.md) | not reported | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ocln/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [COMPASS FINANCIAL MANAGEMENT LLC](/funds/2148724.md) | 2026-06-30 | $413 | 825,890 | | Not compared | ## Recent filings [All 412 filings](/companies/ocln/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-05-29 | 14:22 ET | [10-Q](/filings/0001096906-26-000879.md) | Quarterly report, period 2026-03-31 | 0001096906-26-000879 | | 2026-05-13 | 17:20 ET | [8-K](/filings/0001096906-26-000785.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001096906-26-000785 | | 2026-04-13 | 18:15 ET | [10-K](/filings/0001213900-26-042634.md) | Annual report, period 2025-12-31 | 0001213900-26-042634 | | 2025-11-19 | 16:45 ET | [10-Q](/filings/0001213900-25-112670.md) | Quarterly report, period 2025-09-30 | 0001213900-25-112670 | | 2025-09-03 | 17:25 ET | [8-K](/filings/0001213900-25-084155.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-084155 | | 2025-08-15 | 17:17 ET | [10-Q](/filings/0001213900-25-077581.md) | Quarterly report, period 2025-06-30 | 0001213900-25-077581 | | 2025-05-19 | 08:00 ET | [10-Q](/filings/0001213900-25-045089.md) | Quarterly report, period 2025-03-31 | 0001213900-25-045089 | | 2025-04-08 | 19:04 ET | [8-K](/filings/0001213900-25-029545.md) | 3.02 Unregistered sale of equity | 0001213900-25-029545 | | 2025-03-31 | 14:26 ET | [10-K](/filings/0001213900-25-026104.md) | Annual report, period 2024-12-31 | 0001213900-25-026104 | | 2024-11-19 | 10:10 ET | [10-Q](/filings/0001213900-24-099900.md) | Quarterly report, period 2024-09-30 | 0001213900-24-099900 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-042634.md), filed Apr 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1419793 - Tickers: OCLN - Exchange: OTC - SIC code: 3559 Special Industry Machinery, NEC - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.